SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10047	Companies
204929	Keywords
135181	Articles
108653	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 06/23/2025 at 07:05, 8 months 25 days ago

Sarclisa Gains EU Recommendation for Multiple Myeloma Treatment

Multiple Myeloma Phase 3 Study Sarclisa CHMP Approval Induction Therapy
PRESS RELEASE

published on 06/23/2025 at 07:00, 8 months 25 days ago

Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma
Sarclisa recommended for EU approval by CHMP for transplant-eligible newly diagnosed multiple myeloma based on GMMG-HD7 study. Potential to improve outcomes in frontline setting globally

Multiple Myeloma Sarclisa EU Approval GMMG-HD7 Study CHMP Recommendation
BRIEF

published on 06/20/2025 at 07:05, 8 months 28 days ago

FDA Approves Dupixent for Bullous Pemphigoid Treatment

FDA Approval Dupixent Type 2 Inflammation Bullous Pemphigoid Rare Skin Disease
PRESS RELEASE

published on 06/20/2025 at 07:00, 8 months 28 days ago

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
Dupixent approved in the US as the only targeted medicine for bullous pemphigoid, meeting the critical treatment needs of patients with uncontrolled disease

FDA Approval Chronic Disease Dupixent Type 2 Inflammation Bullous Pemphigoid
BRIEF

published on 06/17/2025 at 13:45, 9 months ago

Sanofi Successfully Prices €1.5 Billion Bond Issue

Bond Issue Corporate Financing Sanofi Fixed-rate Notes Euro Medium Term Note
PRESS RELEASE

published on 06/17/2025 at 13:40, 9 months ago

Press release: Sanofi successfully prices €1.5 billion bond issue
Sanofi successfully prices €1.5 billion bond issue with fixed-rate notes across 2 tranches, using proceeds for general corporate purposes, led by Citigroup and RBC Capital Markets, under Euro Medium Term Note Programme

Financial Markets Bond Issue Sanofi Euro Medium Term Note Programme Fixed-rate Notes
PRESS RELEASE

published on 06/16/2025 at 22:40, 9 months 1 day ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 06/15/2025 at 17:27, 9 months 2 days ago

Sanofi's Dupixent Surpasses Xolair in Phase 4 Study for Chronic Rhinosinusitis with Asthma

Sanofi Dupixent Phase 4 Study CRSwNP Asthma
PRESS RELEASE

published on 06/15/2025 at 17:22, 9 months 2 days ago

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Dupixent outperformed Xolair in treating chronic rhinosinusitis with nasal polyps and coexisting asthma, showing superior efficacy across all key endpoints in a phase 4 study presented at EAACI

Dupixent Phase 4 Study Asthma Xolair Chronic Rhinosinusitis
BRIEF

published on 06/09/2025 at 23:14, 9 months 8 days ago

Sanofi Releases May 2025 Voting Rights and Shares Data

Voting Rights Shares Regulatory Compliance France Sanofi

Accesswire

Published on 03/18/2026 at 11:00, 1 hour 7 minutes ago

Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
Published on 03/18/2026 at 11:00, 1 hour 7 minutes ago

PJX Resources Enhances the Potential to Discover Reduced Intrusion Related Gold System (RIRGS) Type Deposits In the Sullivan Mining District and Announces Stock Option Grant
Published on 03/18/2026 at 09:35, 2 hours 32 minutes ago

Caledonia Mining Corporation Plc Notification of Relevant Change to Significant Shareholder
Published on 03/18/2026 at 01:25, 10 hours 42 minutes ago

Zeus North America Mining Corp. Announces Upsizing and Closing of Final Tranche of Private Placement
Published on 03/18/2026 at 00:30, 11 hours 37 minutes ago

Panther Minerals Announces Appointment of Rick Mah as Chief Financial Officer

View all ACCESSWIRE

EQS Group

Published on 03/18/2026 at 11:42, 25 minutes ago

OHB wins EUR 248 million contract for satellite constellation to monitor the Arctic
Published on 03/18/2026 at 11:27, 39 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 03/18/2026 at 11:21, 45 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 03/18/2026 at 10:28, 1 hour 38 minutes ago

XTPL sets issue price of series Y shares at PLN 65.00, offering size to reach PLN 19.5 million
Published on 03/18/2026 at 10:05, 2 hours 1 minute ago

Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics

Les Echos

Published on 03/18/2026 at 07:00, 5 hours 7 minutes ago

Mersen: A resilient performance in 2025, return to growth expected in 2026
Published on 03/17/2026 at 07:00, 1 day 5 hours ago

Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day 18 hours ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 1 day 18 hours ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 1 day 18 hours ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026

View all LES ECHOS COMFI WIRE